Showing results (451-460 of 466) with videos related to

Sort By:
Pageof 47
Applications in Plant Sciences|August 2, 2021
New targets acquired: Improving locus recovery from the Angiosperms353 probe setTodd G B McLay, Joanne L Birch, Bee F Gunn, et al.
Scientific Reports|September 21, 2018
Child Weight Gain Trajectories Linked To Oral Microbiota CompositionSarah J C Craig, Daniel Blankenberg, Alice Carla Luisa Parodi, et al.
Pituitary|November 18, 2000
Reverse transcription polymerase chain reaction analysis of pituitary hormone, Pit-1 and steroidogenic factor-1 messenger RNA expression in pituitary tumorsM T McDermott, B R Haugen, D F Gordon, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Development of CXCR3 antagonists. Part 4: discovery of 2-amino-(4-tropinyl)quinolinesRoland L Knight, Daniel R Allen, Helen L Birch, et al.
Appetite|May 16, 2022
Effects of the Sleep SAAF responsive parenting intervention on rapid infant weight gain: A randomized clinical trial of African American familiesJustin A Lavner, Jennifer S Savage, Brian K Stansfield, et al.
Neuro-Oncology Advances|April 1, 2026
Marginal diffusion slope as a prognostic imaging biomarker of infiltrating phenotype in glioblastoma; A cancer imaging biomarker roadmap studyAntoine Vallatos, Haitham F I Al-Mubarak, Joanna L Birch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 2007
CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient miceEva J A van Wanrooij, Saskia C A de Jager, Thomas van Es, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivativesRobert J Watson, Daniel R Allen, Helen L Birch, et al.
BMC Bioinformatics|October 17, 2019
VarSight: prioritizing clinically reported variants with binary classification algorithmsJames M Holt, Brandon Wilk, Camille L Birch, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) InhibitorsChristopher A Luckhurst, Perla Breccia, Andrew J Stott, et al.
Pageof 47